Comments on ICER’s Draft Evidence Report: High Cholesterol Therapies

December 10, 2020

Effective treatments that reduce the risk factors associated with ASCVD offers tremendous value to the patient community.

Read the Letter

Categorized in: Analysis

◀ Next Post

Previous Post ►